These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 35577506)

  • 21. Correction: Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway.
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38740466
    [No Abstract]   [Full Text] [Related]  

  • 22. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.
    Redin E; Garmendia I; Lozano T; Serrano D; Senent Y; Redrado M; Villalba M; De Andrea CE; Exposito F; Ajona D; Ortiz-Espinosa S; Remirez A; Bertolo C; Sainz C; Garcia-Pedrero J; Pio R; Lasarte J; Agorreta J; Montuenga LM; Calvo A
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33658304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway.
    Wang R; Deng Z; Zhu Z; Wang J; Yang X; Xu M; Wang X; Tang Q; Zhou Q; Wan X; Wu W; Wang S
    Phytomedicine; 2023 Dec; 121():155090. PubMed ID: 37738907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
    Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
    J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway.
    Li R; Chai L; Lei L; Guo R; Wen X
    Mol Biotechnol; 2023 Sep; 65(9):1421-1431. PubMed ID: 36630073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway.
    Guo Z; Ye H; Zheng X; Yin W; He J
    J Cell Physiol; 2021 May; 236(5):3808-3820. PubMed ID: 33258116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway.
    Yu T; Zhao Y; Hu Z; Li J; Chu D; Zhang J; Li Z; Chen B; Zhang X; Pan H; Li S; Lin H; Liu L; Yan M; He X; Yao M
    Cancer Res; 2017 Nov; 77(21):5782-5794. PubMed ID: 28923857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
    Chen GM; Zheng AJ; Cai J; Han P; Ji HB; Wang LL
    J Cell Biochem; 2018 Jan; 119(1):885-895. PubMed ID: 28661070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PHF12 regulates HDAC1 to promote tumorigenesis via EGFR/AKT signaling pathway in non-small cell lung cancer.
    Kong Y; Jiang R; Zhou H; Ge M; Lin H; Wang Y; Yao R; Wang Q; Liang X; Li J; Zhou X
    J Transl Med; 2024 Jul; 22(1):689. PubMed ID: 39075515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.
    Liang Z; Zhong Y; Meng L; Chen Y; Liu Y; Wu A; Li X; Wang M
    Thorac Cancer; 2020 Nov; 11(11):3155-3167. PubMed ID: 32926529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.